Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Bioeconomy Blueprint Suggestions
President Barack Obama’s administration has begun reviewing suggestions for a strategic plan or National Bioeconomy Blueprint detailing measures by which the Obama administration intends to apply biological research innovations toward national challenges that include health, food, energy, and the environment. The administration’s Office of Science and Technology Policy (OSTP) posted on its website that it received 134 submissions to a formal Request for Information (RFI) between October 7 and the December 6 deadline. Responses came from a cross-section of industry and professional groups focused on the life sciences, as well as biotech and pharma companies, research institutions, universities, and individuals. What do you think of the suggestions made?